Ted Pellas
Ed, Head of Oncology Imaging, Oncology Clinical Development @GSK
Signup · Get unlimited contacts
WORK HISTORY
Ed, Head of Oncology Imaging, Oncology Clinical Development @GSK
EDUCATION
University of Pennsylvania
VMD (DVM), School of Veterinary Medicine
Penn State University
Bachelor's Degree, Animal Science
University of Pennsylvania
PhD, Experimental Pathology/Immunology
Penn State University
Master's Degree, Animal Physiology
SKILLS
ABOUT TED PELLAS
Exec. Dir, Imaging Lead, Oncology Clinical Development GSK R&D with extensive preclinical, translational, early, and late phase clinical imaging experience in biopharmaceutical drug development. Specialty areas include Immuno-Oncology, Oncology, Immunology, and Musculoskeletal Imaging. Proficient at leading clinical imaging strategy and execution in Oncology & IO clinical trials (immune checkpoint inhibitors/agonists, targeted therapy, cell imaging, synthetic lethality, ADCs, combination trials), with cross-portfolio standardization & harmonization (via templates, smart EDC, SDTM/CDISC output, etc.). Subject matter expert in tumor assessment criteria. Experienced in quantitative molecular PET imaging probe development using large molecule vectors (antibodies, mAb fragments, etc.) in pre-clinical development, including applications for cell imaging, T cell effector imaging, tumor imaging, etc.AREAS OF EXPERTISE & COLLABORATIONImmuno-Oncology/Oncology Clinical Research | Biologics, Antibodies, ADCs, Small Molecules | GxP, ICH; CRF, ICF | Clinical Study Protocols / Templates | Imaging CROs, Imaging Charters, DTS | CMC Biologics Manufacturing | Ad Boards, Steering Committees, Site Initiations | Budget, Portfolio & basic Project Management | Tumor Immunology, Cancer Immunotherapy: CTLA-4, PD-1, PD-L1, Nivolumab, Ipilimumab, Durvalumab, Tremelimumab, Dostarlimab; Targeted therapy: mTOR, Brivanib, IGF-1R, Jak2, CXCR4, Smoothened, Notch, Imatinib, Deferasirox | Autoimmunity (Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis): Abatacept, Clazakizumab, Canakinumab, Secukinumab | Data Visualization, Spotfire | Molecular Imaging: PET/MRI/CT/DEXA/Optical | Pharmacology; PK/PD | Mesenchymal Stem Cell tissue regeneration | Structural Biology, Molecular Pathology• Demonstrated matrix accountability and leadership skills as an Imaging SMEmisspellings Theadore Pelas Pellis Pallas
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.